HB 30 (BR 177) - M. Marzian, C. Embry Jr., B. Housman, D. Watkins
AN ACT relating to health care services provided in clinical trials for the treatment of cancer.
Create a new section of Subtitle 17A of KRS Chapter 304 to prohibit a health benefit plan from excluding coverage for routine patient healthcare costs that are incurred in the course of a cancer clinical trial if the health benefit plan would provide coverage for the routine patient healthcare cost had it not been incurred in a cancer clinical trial; provide that nothing in this section requires a policy to offer, nor prohibit a policy from offering, cancer clinical trial services by a participating provider; provide that nothing in this section requires services that are performed in a cancer clinical trial by a non-participating provider of a policy to be reimbursed at the same rate as those performed by a participating provider of the policy.
HB 30 - AMENDMENTS
HFA (1, M. Marzian) - Amend the exclusion from "routine patient healthcare costs" to include any treatment outside the usual and customary standard type and frequency of any diagnostic modality and delete any treatment modality care required to administer or support the service item or investigational drug that is the subject of the clinical trial.
(Prefiled by the sponsor(s).)
Jan 6-introduced in House
Jan 7-to Banking & Insurance (H)
Feb 9-posting waived
Feb 11-reported favorably, 1st reading, to Calendar
Feb 12-2nd reading, to Rules; posted for passage in the Regular Orders of the Day for Friday, February 13, 2009
Feb 24-floor amendment (1) filed
Feb 25-3rd reading, passed 99-0 with floor amendment (1)
Feb 26-received in Senate
Mar 2-to Banking & Insurance (S)